Tag Archives: New Tuberculosis (TB) Treatment Regimen

New Tuberculosis (TB) Treatment Regimen

GS II-Health Key Developments in TB Treatment WHO Recommendations (2022): The World Health Organization (WHO) endorsed the six-month BPaL regimen (bedaquiline, pretomanid, linezolid) and BPaLM regimen (BPaL + moxifloxacin) as viable options for drug-resistant TB treatment. Advanced Diagnostic Expansion: India plans to scale up the Nucleic Acid Amplification Test (NAAT) …

Read More »